Matsuoka et al. reported that the blockade of IL-6 signaling, combined with conventional RT, augments the treatment response and survival rate in patients with radioresistant oral squamous cell carcinoma [27]. This evidence concerns the gene IL6 and oral cavity squamous cell carcinoma.